Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2010
03/17/2010CN101670118A Application of miR-155 in preparing medicine for curing gastricism
03/17/2010CN101670117A Application of miR-146a in preparing medicine for curing gastricism
03/17/2010CN101670097A Application of cartilage oligomeric matrix protein in preparing medicine for treating vascular-calcification
03/16/2010US7678774 Treating severe acute respiratory syndrome
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010CA2087817C 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use
03/11/2010WO2010028367A1 Gold nanorod-sirna complexes and methods of using same
03/11/2010WO2010028313A2 Phosphoprotein analysis of carcinomas for assessment of drug sensitivity
03/11/2010WO2010028093A2 Use of a truncated elf-5a1 polynucleotide to induce apoptosis in cancer cells
03/11/2010WO2010028079A2 Synthetic methods and derivatives of triphosphate oligonucleotides
03/11/2010WO2010027830A2 Methods for modulation of connective tissue growth factor expression by administering antisense oligonucleotides through a delivery system so as to reduce scarring from wound healing and threat fibrotic diseases
03/11/2010WO2010026766A1 Agent for treating myelofibrosis
03/11/2010WO2010026213A2 Treatment of scleroderma
03/11/2010WO2010025555A1 Periostin-induced pancreatic regeneration
03/11/2010WO2009143483A9 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION
03/11/2010WO2009126651A9 Mat ii subunit rnai and therapeutic methods using same
03/11/2010WO2009116037A3 NOVEL siRNA COMPOUNDS FOR INHIBITING RTP801
03/11/2010WO2009082593A3 Dendritic cell vaccine compositions and uses of same
03/11/2010US20100063260 Whitefly Ecdysone Receptor Antibody
03/11/2010US20100063134 comprising the steps of surgically implanting a catheter ; without impairment of cell endoplasmic reticulum, spontaneous motor activity, or locomotor activity; Alzheimer's, Parkinson's, Huntington's diseases, Spinocerebellar Ataxia Type 1, Type 2, Type 3, and/or dentatorubral-pallidoluysian atrophy
03/11/2010US20100063052 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
03/11/2010US20100062443 Using myeloblastosis oncogene expression profile as tool in detection of cell proliferative disorders associated with respiratory system
03/11/2010US20100062049 Aqueous formulation for selective targeting and delivering gene to cancer cells
03/11/2010US20100062016 Microorganisms for therapy
03/11/2010US20100062013 Cancer antigen peptides derived from wt1
03/11/2010US20100062003 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
03/11/2010US20100061992 Therapeutic uses of tim-3 modulators
03/11/2010US20100061984 Compositions and methods for modulation of suppressor t cell activation
03/11/2010CA2736314A1 Periostin-induced pancreatic regeneration
03/11/2010CA2735823A1 Use of a truncated eif-5a1 polynucleotide to induce apoptosis in cancer cells
03/11/2010CA2735709A1 Agent for treating myelofibrosis
03/10/2010EP2161340A2 Optimized T-DNA transfer and vectors therefor
03/10/2010EP2161286A1 Antibodies
03/10/2010EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
03/10/2010EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof
03/10/2010EP2021484B1 Expression vectors comprising the hs1 promoter of the vav1 oncogene and use thereof for the preparation of pharmaceutical compositions intended for somatic gene therapy
03/10/2010EP1692293B1 Adenovirus-transfected primary cells and methods of pathway mapping
03/10/2010EP1677833B1 Virus vector for use in in vivo gene therapy of Parkinson's disease
03/10/2010EP1483588B1 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
03/10/2010EP0932678B2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
03/09/2010US7674896 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
03/09/2010US7674889 makes it possible to detect the expression of the same in various tissues, analyze their structures and functions, and produce the human proteins encoded by the genes by genetic engineering; hereditary diseases and cancer
03/09/2010US7674888 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
03/09/2010US7674778 Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010US7674470 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
03/09/2010US7674464 Intracellular interleukin-1 receptor antagonists
03/09/2010US7674463 Method of inhibiting angiogenesis by administration of a corticotropin releasing factor receptor 2 agonist
03/09/2010US7674458 Lysyl oxidase-like 1 (LOXL1) and elastogenesis
03/09/2010US7674455 treating a mammal having amyotrophic lateral sclerosis by transducing a motor neuron of the mammal with an insulin-like growth factor I (IGF-1) gene or a glial cell line-derived neurotrophic factor (GDNF) gene; neurodegenerative disorders
03/09/2010US7674454 Enzyme-prodrug therapy for prosthetic joint repair
03/09/2010CA2420495C A novel cationic lipopolymer as biocompatible gene delivery agent
03/09/2010CA2389476C Treatment of dyskinesia with a h3-histamine receptor agonist
03/09/2010CA2382464C High-affinity choline transporter
03/09/2010CA2172153C Regulation of bcl-2 gene expression
03/04/2010WO2010025177A1 Method and compositions for enhanced anti-tumor effector functioning of t cells
03/04/2010WO2010024711A1 Method for treating oncological diseases
03/04/2010WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same
03/04/2010WO2010024384A1 Anti-hepatitis c virus composition
03/04/2010WO2010024262A1 Transfection agent
03/04/2010WO2010023917A1 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof
03/04/2010WO2010023866A1 Syngr4 for target genes of cancer therapy and diagnosis
03/04/2010WO2010023838A1 Tbc1d7 as tumor marker and therapeutic target for cancer
03/04/2010WO2010023837A1 Breast cancer related gene rqcd1
03/04/2010WO2010023544A1 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction
03/04/2010WO2010022553A1 An endogenous short hairpin rna and the use of the same
03/04/2010WO2010000849A3 Conserved secreted proteins from protozoan parasites
03/04/2010WO2009140676A3 Compositions and methods for inhibition of retroviruses
03/04/2010WO2009140432A3 Micelles for intracellular delivery of therapeutic agents
03/04/2010WO2009140427A3 Diblock copolymers and polynucleotide complexes thereof for delivery into cells
03/04/2010US20100056447 Immunization against chlamydia pneumoniae
03/04/2010US20100055763 Method for the production and purification of retroviral vectors
03/04/2010US20100055167 Stem cell delivery of anti-neoplastic medicine
03/04/2010US20100055150 Method and composition for treatment of skeletal dysplasias
03/04/2010US20100055130 Staphylococcus aureus proteins and nucleic acids
03/04/2010US20100055128 Method for the purification of alphavirus replicon particles
03/04/2010US20100055124 BRACHYSPIRA PILOSICOLI 72kDa OUTER-MEMBRANE PROTEIN AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
03/04/2010US20100055122 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
03/04/2010CA2735456A1 Method and compositions for enhanced anti-tumor effector functioning of t cells
03/04/2010CA2735182A1 Tbc1d7 as tumor marker and therapeutic target for cancer
03/04/2010CA2734979A1 Syngr4 for target genes of cancer therapy and diagnosis
03/03/2010EP2159230A1 Anti-TNF antibodies, compositions, methods and uses
03/03/2010EP2158316A2 Gene expression and pain
03/03/2010EP2158211A2 Mutated structural protein of a parvovirus
03/03/2010EP2157982A2 Amino acid lipids and uses thereof
03/03/2010EP1813289B1 Medicinal composition for treating cancer or diabetes
03/03/2010EP1567662B1 Caged sensors, regulators and compounds and uses thereof
03/03/2010EP1519952B1 Use of aspartic proteases in cosmetics and therapeutics
03/03/2010EP0990030B1 Transcriptional activators with graded transactivation potential
03/03/2010EP0973381B1 Animal model for evaluation of vaccines
03/02/2010US7671258 Surfactant peptide nanostructures, and uses thereof
03/02/2010US7671250 Mammal that has acquired immunological tolerance to a foreign DNA and/or its expression product; expresses a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes
03/02/2010US7671180 Heparin binding protein for use in diagnosis, prvention and treatment of cell proliferative, liver, neurodegeneartive, inflammatory and pancreatic disorders; wound healing agents
03/02/2010US7671036 Positively-charged peptide nucleic acid analogs with improved properties
03/02/2010US7671035 Epidermal growth factor receptor antisense oligonucleotides
03/02/2010US7670773 detecting Rett syndrome, a neuropsychiatric disorder
03/02/2010US7670767 Genetic alterations associated with cancer
03/02/2010US7670766 Early detection of flaviviruses using the NS1 glycoprotein
03/02/2010US7670611 Cancer immunotherapy with semi-allogeneic cells
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 870